🔎 Trials Near Me

መነሻ › ማይሎፋይብሮሲስ › New York › New York City

በNew York City፣ NY ለማይሎፋይብሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለማይሎፋይብሮሲስ የሚደረጉ 18 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Icahn School of Medicine at Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Memorial Sloan Kettering Cancer Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07623161

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • NYP/Weill Cornell Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06661915

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Memorial Sloan Kettering Cancer Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Montefiore, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05320198

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
  • Icahn School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06343805

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Icahn School of Medicine At Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07008118

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ጁላይ 2026 · NCT06773195

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
  • Mount Sinai School of Medicine, New York
  • Weill Cornell Medicine, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT07441694

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ruttenberg Treatment Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • NewYork-Presbyterian/Weill Cornell Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT05835466

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT06517875

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Icahn School of Medicine At Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኤፕሪ 2026 · NCT06034002

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering, New York
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Weill Cornell Medicine NewYork-Presbyterian, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ፌብሩ 2026 · NCT05980806

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጃንዩ 2026 · NCT07362225

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ruttenberg Treatment Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ዲሴም 2025 · NCT06541249

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, New York
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • ICAHN School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2025 · NCT06479135

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Columbia University, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2025 · NCT05423691

በሌሎች ከተሞች ለማይሎፋይብሮሲስ የሚደረጉ ጥናቶች

በNew York City ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።